Spots Global Cancer Trial Database for Percutaneous Cryoablation Peripheral Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Percutaneous Cryoablation Peripheral Lung Cancer
Official Title: Percutaneous Cryoablation for the Treatment of Medically Inoperable Peripheral Lung Cancer
Study ID: NCT02665390
Conditions
Interventions
Study Description
Brief Summary: This study is focus on percutaneous cryoablation,which was for the treatment of medically inoperable Peripheral lung cancer.The patients who were agreed to attend the study will accept the operation. After the operations,they will follow up according to the plan.
Detailed Description: The patients who were agreed to attend the study conclude early stage lung cancer and solitary metastatic lung cancer.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Sun jiayuan, MD
Affiliation: Shanghai Chest Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
